Drug Manufacturers - Major

Articles

  1. It's No Accident That Drugs Are Expensive

    Branded drugs are expensive in large part because it's expensive and risky to develop ...
  2. Will Immunotherapy Disrupt The Oncology Market?

    Immunotherapy could radically change the treatment of cancer, and the revenue opportunities ...
  3. 8 Stages Of New Drug Development

    Understanding biotech data isn't easy. What is a clinical trial, what are the various ...
  4. Big Pharma Faces 'Pay For Delay' Lawsuits

    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve ...

Stock Analysis

  1. Yet Another Failure Has Rigel Pharmaceuticals ...

    Rigel sees yet another clinical failure from its pipeline.
  2. AstraZeneca Goes Back To The M&A Well Yet Again

    AstraZeneca's acquisition of Amplimmune could pay big dividends in a decade.
  3. Amgen Sweetens The Bid And Secures Onyx

    Amgen finalizes a value-additive deal for Onyx
  4. Novo Nordisk Getting Its Trial By Fire

    Novo Nordisk is facing more challenges than it has in a while, but the growth remains ...
  5. Can Sanofi Investors Just Blame It On Rio?

    Can Sanofi Investors Just Blame It On Rio? By Stephen D. Simpson, CFA Sanofi ...
  6. Better Margins Can't Hide Merck's Growth Challenges

    Merck's near-term growth is looking weak, but margin improvements and an underestimated ...
Investopedia Features
  1. Choosing Quality Mutual Funds

    Our step-by-step mutual fund scoring system will help you uncover the top-quality funds.
  2. Guide to Stock Picking Strategies

    Learn about the most popular stock-picking strategies, including their philosophies, methods, and tools.
  3. Advanced Financial Statement Analysis

    Learn what it means to do your homework before investing in a company.
  4. World's Greatest Investors

    Here you can read about the backgrounds and achievements of those people who have mastered the art of investing.
  5. The Industry Handbook

    Take a look at the various techniques to determine the value and quality of companies from an industry perspective.
Trading Center